1	8 Concomitant use of vigabatrin Subjects who took vigabatrin in the past must be discontinued for approximately 5 months prior to Baseline and must have documentation showing no evidence of a vigabatrin-associated clinically significant abnormality in an automated visual perimetry test|vigabatrin[21,31]|||||||5 months[112,120]||C0048044|14851|14851|vigabatrin
1	8 Concomitant use of vigabatrin Subjects who took vigabatrin in the past must be discontinued for approximately 5 months prior to Baseline and must have documentation showing no evidence of a vigabatrin-associated clinically significant abnormality in an automated visual perimetry test|vigabatrin[50,60]|||||||||C0048044|14851|14851|vigabatrin
1	8 Concomitant use of vigabatrin Subjects who took vigabatrin in the past must be discontinued for approximately 5 months prior to Baseline and must have documentation showing no evidence of a vigabatrin-associated clinically significant abnormality in an automated visual perimetry test|vigabatrin[192,202]|||||||||C0048044|14851|14851|vigabatrin
